Pressure-Treated Yeast Fiber Compounds May Benefit IPF Patients

Pressure-Treated Yeast Fiber Compounds May Benefit IPF Patients

311985

Pressure-Treated Yeast Fiber Compounds May Benefit IPF Patients

An inhalable therapeutic is being developed using pressure-treated yeast beta-glucan for people with COVID-19 as well as other severe lung diseases, including idiopathic pulmonary fibrosis (IPF). Beta-glucans are fiber compounds that are naturally found in the cell walls of grains, bacteria, and fungi, such as yeast. Ceapro, a biotechnology company based in Alberta, Canada, uses its patented Pressurized Gas eXpanded (PGX) technology to transform beta-glucans into highly soluble dry microparticles or free-flowing powders with adjustable particle…

You must be logged in to read/download the full post.